LFCR (Lifecore) שולי הרווח הגולמי

LFCR (Lifecore Biomedical) - סמל מסחרי של החברה

Comparing the gross margin level on GURU.Markets, we see that the metric value is 0.00. Lifecore Biomedical (LFCR) strives for leadership in the complex injectables CDMO segment by integrating into the supply chains of industry behemoths. Stable demand in ophthalmology makes the business crisis-resistant. Current efficiency growth is driven by the recovery of production volumes and the resolution of previous reporting issues.

lifecore.com (LFCR): רווחיות גולמית מ-28.04.2023 עד 19.11.2026

פילוחי מדדים פיננסיים ומדדי שוק עבור lifecore.com (LFCR)

- מדדי הערכת שווי שוק של העסק:
ניתוח מסכם של החברה:Lifecore Biomedical (LFCR)
מוצרים מיוצרים של Lifecore Biomedical

Gross margin is calculated as the ratio of the difference between revenue and direct cost of goods sold to total sales, measuring the efficiency of production cost management. For Lifecore Biomedical (LFCR), this indicator reflects the monetization of unique competencies in the production of complex viscous drugs, which is clearly evidenced by the monthly gross margin trend as a measure of the company's technological superiority over its competitors.